Tirzepatide, novel agent for treating type 2 diabetes has different efficacy in Asians and non-Asians: Study
China: A recent meta-analysis published in Diabetes Therapy has shed light on the comparative safety and efficacy of tirzepatide in Asians and non-Asians with type 2 diabetes mellitus (T2DM). Jianjun Dong, Shandong University, Jinan, Shandong, China, and colleagues revealed that tirzepatide is a novel agent for diabetes treatment and has different efficacy in Asians and […]